News

Find News

Filter articles

Showing 2411 to 2420 of 2503 results

Horizon Pharma settles Duexis case with Par Pharmaceuticals

US22-08-2013Legal developments

US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies.

Roche relinquishes patent on breast cancer drug

India19-08-2013

Drugmaker Roche has decided not to pursue a patent application for a breast cancer drug in the Indian market, enabling rivals to possibly produce cheaper versions.

Allergan sued over breast implant patent

US14-08-2013

Texas-based Almha has launched patent infringement lawsuits against four companies, including UK company Allergan, in relation to its patent covering a “breast implant with position lock”.

Sheppard Mullin hires partner in California

US14-08-2013

Lorna Tanner has joined the Palo Alto office of Sheppard Mullin Richter & Hampton LLP as an IP partner.

SIPO pulls Viread patent – victory for pharma innovators?

China13-08-2013

The Chinese State Intellectual Property Office (SIPO) has revoked a patent covering biopharmaceutical company Gilead Science’s HIV drug Viread, Reuters subsidiary news site BioWorld reported.

IPAB revokes Allergan eye drug patent

India12-08-2013Legal developments

On August 8 the IPAB revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.

Myriad patent suit enters antitrust territory

US08-08-2013

Ambry Genetics, the laboratory sued last month by biotech company Myriad over patents covering the BRCA1 and BRCA2 genes, has hit back with antitrust claims.

Indian patent office strikes down another blockbuster patent

India07-08-2013

The Kolkata Patent Office has refused divisional patents related to Swiss pharmaceutical company Roche’s breast cancer drug Herceptin.

Eversheds secures former Sidley Austin IP and life sciences head

UK06-08-2013

Eversheds has appointed the former head of Sidley Austin's London IP and life sciences team Brett Rowland, as a partner.

Roche signs drug licensing agreement with MPP

Switzerland05-08-2013

On August 5, Swiss pharmaceutical company Roche signed an agreement with the MPP to increase access to its drug valganciclovir (Valcyte), an oral medicine for the treatment of preventable viral infection cytomegalovirus (CMV).

Showing 2411 to 2420 of 2503 results

LSIPR